share_log

Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis

Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis

theratechnologies宣佈已與ionis pharmaceuticals達成協議,授權使用ionis研發的兩種RNA靶向藥物。
Benzinga ·  12/04 20:40
Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論